http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3939145-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_244aff88c05f006ed6775b1a9c25883d |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7042 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7052 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7028 |
filingDate | 1973-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1976-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9ddb4d9f1fa4da135e6cec819f6cfb5 |
publicationDate | 1976-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-3939145-A |
titleOfInvention | Novel ethereally monosubstituted monosaccharides |
abstract | The invention provides a novel therapeutic composition comprising a pharmaceutically acceptable carrier containing a therapeutically effective amount of an ethereally monosubstituted monosaccharide having the general formula S-O-Y, wherein S is the residue of a monosaccharide selected from the group consisting of pentoses, hexoses and heptoses and Y is selected from the group consisting of cyclic monovalent nitrogen containing organic radicals and residua and monovalent organic radicals and residua having the general formula -R1-N-R3, ¦ R2 wherein R1 is a divalent organic radical having a linear carbon chain length of about 1-7 carbon atoms and R2 and R3 are selected from the group consisting of -H, -OH, -SH, halogen and monovalent organic radicals and residua having a linear carbon chain length of about 1-7 carbon atoms. The invention also provides certain novel ethereally monosubstituted monosaccharides, of which 3-O-3'-(N',N'-dimethylamino-n-propyl)-D-glucose is an example. The novel monosaccharides show striking antiviral activity or other therapeutically valuable properties and are useful as an active ingredient in the above therapeutic composition. The invention further provides a method of therapeutically treating warm blooded animals with the aforementioned therapeutic composition and novel monosubstituted monosaccharides. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5298494-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5360792-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4738953-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004146532-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4251520-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4996195-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4228274-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5010058-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6060453-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4868289-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5344924-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5399201-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5157024-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5432163-A |
priorityDate | 1973-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 196.